Ray Dingledine trained in neurophysiology in Oslo under Per Andersen and has since then had close relations with Norway.
He has performed fundamental studies on glutamate receptors, and currently on inflammatory mechanisms in neurotransmission and epilepsy. In recent years, he has taken interest in how we as scientists make decisions, including on how data should be interpreted. One reason for this interest is the fact that scientific findings often prove hard to reproduce.
13:00 "Innate immunity targets in epilepsy"
13:45 Questions / Discussion
14:15 "Why is it so hard to do good science?"
15:00 Discussion: How do scientists make judgments on how to interpret their data?
16:00 End of seminar
Coﬀee and 'kringle' will be served.
Raymond J Dingledine is Professor and past Chairman of the Department of Pharmacology at Emory University School of Medicine. Ray received his PhD in pharmacology under Avram Goldstein at Stanford and postdoctoral training from Leslie Iversen and John Kelly at Cambridge, UK, then Per Andersen at Oslo.
His research focuses on the pharmacology of glutamate receptors and on the causes of epilepsy. He serves on the scientiﬁc advisory boards of The Epilepsy Project and NeurOp, a clinical-stage biotech start-up he co-founded. He is also chair of the Investment Committee of the Society for Neuroscience. He is a member of the National Academy of Medicine and the Norwegian Academy of Science and Letters.